AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ERYTHROMICINE
11 registrations across 1 African market— 5 active
Markets with ERYTHROMICINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| ERYTHROMYCINE BAILLEUL 4% SOLUTION POUR APPLICATION CUTANEE FLACON DE 100ML | 🇨🇮Côte d'Ivoire | LABORATOIRE BAILLEUL | active | Dec 2027 |
| ERYFLUID 4G/100 ML LOTION FLACON DE 100ML | 🇨🇮Côte d'Ivoire | PIERRE FABRE DERMATOLOGIE | expired | Dec 2025 |
| ERYTHROMYCINE CREAT 500MG COMPRIME PELLICULE BOITE DE 100 | 🇨🇮Côte d'Ivoire | BAILLY CREAT | expired | Jan 2025 |
| ERYTHROMYCIN AFRICURE 500MG COMPRIME BOITE DE 20 | 🇨🇮Côte d'Ivoire | AFRICURE PHARMACEUTICALS CI SA | expired | Oct 2024 |
| MACROCID 500MG COMPRIME PELLICULE BOITE DE 20 | 🇨🇮Côte d'Ivoire | LABORATOIRES PHARMA 5 | expired | Jan 2023 |
| CARY-500 500MG COMPRIME BOITE DE 10 | 🇨🇮Côte d'Ivoire | CAPLIN POINT LABORATORIES LIMITED R.S.N | expired | Mar 2021 |
| CARY 125-5ML SUSPENSION BUVABLE FLACON DE 60ML | 🇨🇮Côte d'Ivoire | CAPLIN POINT LABORATORIES LIMITED R.S.N | expired | Oct 2020 |
| ERYTHROMYCIN AFRICURE 250MG COMPRIME BOITE DE 100 | 🇨🇮Côte d'Ivoire | AFRICURE PHARMACEUTICALS CI SA | active | — |
| ERYSEPT 4% GEL TUBE DE 30G | 🇨🇮Côte d'Ivoire | PHARMA PRODUCT MANUFACTURING (PPM) | active | — |
| ERYTHROMYCIN AFRICURE 500MG COMPRIME BOITE DE 100 | 🇨🇮Côte d'Ivoire | AFRICURE PHARMACEUTICALS CI SA | active | — |
| LYERY 250MG SACHET BOITE DE 24 | 🇨🇮Côte d'Ivoire | HEALTHILY PHARMA | active | — |
ERYTHROMICINE in Africa — Regulatory Overview
ERYTHROMICINE is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.
Of the 11 registrations, 5 (45%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.